Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych MEQs / SAQsGeneral adult psychiatry — personality disorders

Psych MEQs / SAQs · General adult psychiatry — personality disorders

Borderline personality disorder — crisis assessment and stepped management (MEQ)

FRANZCP-style modified essay on BPD crisis: risk formulation, differentials including bipolar and substance use, least-restrictive crisis care, DBT/MBT structure, and limited pharmacotherapy with review dates. FRANZCP-primary, globally tagged.

20 marks20 min
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 26-year-old woman is brought to ED after taking 20 sertraline tablets and cutting her forearms following a relationship breakup. She has a 6-year history of recurrent self-harm, unstable relationships, identity disturbance, intense anger, and chronic emptiness. She describes mood swings lasting hours. She drinks heavily when distressed. She denies current intent to die but says 'I want the pain to stop.' Observations are stable after medical clearance. (i) Outline your risk assessment priorities specific to BPD. (ii) State working diagnosis and key differentials with discriminators. (iii) Outline immediate crisis management and disposition options. (iv) Propose a medium-term treatment plan including a named psychotherapy model with structure. (v) State principles of pharmacotherapy and one named medication scenario with monitoring/review. (20 marks)

Model answer

Reveal model answer

(i) Risk assessment priorities. Separate medical from psychiatric risk. Confirm medical clearance after overdose. Assess ideation, intent, plan, lethality of this attempt (20 tablets + cutting — low-moderate lethality but intent can change), access to further means (stockpiled meds, alcohol), prior attempts, hopelessness, protective factors (friend present, future-oriented statements), impulsivity, intoxication, and abandonment trigger. Distinguish acute wish to die from non-suicidal self-injury as affect regulation — she currently denies intent but the overdose still requires full assessment. Dynamic risk is elevated post-breakup and with alcohol. Capacity for discharge decisions; safeguarding if dependents; collateral if available. Document chronic baseline risk versus today's acute change.[5]

(ii) Working diagnosis and differentials. Working diagnosis: borderline personality disorder (DSM ≥5/9 features described longitudinally) with acute crisis after interpersonal rupture, alcohol misuse, and deliberate self-harm/overdose. Differentials/comorbidities: major depressive episode (screen systematically); bipolar spectrum (hours-long swings argue against mania/hypomania duration thresholds; still ask sleep need, elevated periods); substance-induced dysregulation; PTSD if trauma history; ADHD if lifelong neurodevelopmental pattern. Organic exclusion already partly addressed by medical clearance; revisit if atypical features emerge.[5]

(iii) Immediate crisis management. Validate distress; problem-solve the breakup crisis; collaborative safety plan; means restriction (secure medications, reduce alcohol access); least-restrictive disposition — consider discharge with same-day/next-day crisis team or community follow-up if acute risk is containable, versus brief crisis admission if intent escalates, supports fail, or intoxication/impulsivity remains high. Avoid both pejorative dismissal and open-ended admission without plan. Named clinician and written crisis contacts. Local Mental Health Act only if imminent risk and statutory criteria met — do not invent section numbers.[1][5]

(iv) Medium-term plan. Psychoeducation that BPD is treatable. Offer structured evidence-based psychotherapy. Example: DBT — individual therapy, skills group (mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness), consultation team, phone coaching where available; hierarchy prioritises life-threatening behaviours. If DBT unavailable, structured clinical management / GPM is an evidence-supported alternative (McMain). Address alcohol with motivational work. Consistent team approach to reduce splitting.[1][2]

(v) Pharmacotherapy principles. No drug treats BPD as a whole (NICE/Cochrane stance). Do not start lamotrigine as default BPD stabiliser (LABILE negative). Treat comorbidity. Example scenario: if a comorbid major depressive episode is confirmed without bipolarity, sertraline may be continued/restarted carefully after overdose review (note she overdosed on sertraline — means restriction, limited dispensing, early review for activation/suicidality). Any symptom-targeted antipsychotic would need a written target and stop date. Avoid chronic benzodiazepines for emotion regulation.[3][4]

Common errors

  • Calling the presentation “attention-seeking” without risk formulation.
  • Automatic long involuntary admission for all self-harm.
  • Starting three psychotropics on first contact.
  • Claiming no effective treatments exist.
  • Inventing Mental Health Act section numbers. [4][5]

Examiner notes

Full marks require BPD-specific risk language, bipolar discrimination, least-restrictive crisis plan, a named psychotherapy with structure, and pharmacotherapy restraint with LABILE/NICE awareness.[1][3][4]

References

  1. [1]McMain SF, Links PS, Gnam WH, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder Am J Psychiatry, 2009.PMID 19755574
  2. [2]Linehan MM, Comtois KA, Murray AM, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder Arch Gen Psychiatry, 2006.PMID 16818865
  3. [3]Crawford MJ, Sanatinia R, Barrett B, et al. The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled Trial Am J Psychiatry, 2018.PMID 29621901
  4. [4]Kendall T, Burbeck R, Bateman A Pharmacotherapy for borderline personality disorder: NICE guideline Br J Psychiatry, 2010.PMID 20118465
  5. [5]Bohus M, Stoffers-Winterling J, Sharp C, et al. Borderline personality disorder Lancet, 2021.PMID 34688371